We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images

By MedImaging International staff writers
Posted on 14 Mar 2024
Image: A cardiac ultrasound examination being performed on a 7-week old infant (Photo courtesy of ETH Zurich)
Image: A cardiac ultrasound examination being performed on a 7-week old infant (Photo courtesy of ETH Zurich)

Pulmonary hypertension is a condition where the arteries going to an infant’s lungs don't open wide enough or close back up soon after birth. This makes it hard for blood to get to the lungs and for the infant to get enough oxygen. It's really important to find and treat this problem quickly to help the infant get better. However, figuring out if an infant has pulmonary hypertension is tough and usually only very skilled heart doctors can do it by looking at heart ultrasounds. Now, researchers have developed an artificial intelligence (AI) model that can help diagnose the disease in newborns.

Researchers at ETH Zurich (Zurich, Switzerland) developed the AI model by training their algorithm on videos from heart ultrasound recordings of 192 newborns. These videos showed the heart beating from different sides and included the heart doctors' views on whether the baby had pulmonary hypertension and the severity of the condition. Then, they tested the AI model using a second dataset of ultrasound images from 78 newborn infants. The AI model correctly diagnosed whether the baby had pulmonary hypertension in about 80 to 90% of the cases and was also correct about the severity in about 65 to 85% of cases.

The AI model also highlights the parts of the ultrasound image on which its categorization is based, allowing doctors to know exactly which areas or characteristics of the heart and its blood vessels it considers suspicious. This AI model could be potentially applied to other organs and diseases, such as for diagnosing heart septal defects or valvular heart disease. It could also find application in regions where specialists are unavailable: the model could examine standardized ultrasound images taken by a healthcare professional and provide a preliminary risk assessment along with an indication of whether a specialist should be consulted. Medical facilities without access to highly qualified specialists could use the AI model to reduce their workload and achieve a better diagnosis.

“The key to using a machine-​learning model in a medical context is not just the prediction accuracy, but also whether humans are able to understand the criteria the model uses to make decisions,” said Julia Vogt from ETH Zurich who led the research group. “AI has the potential to make significant improvements to healthcare. The crucial issue for us is that the final decision should always be made by a human, by a doctor. AI should simply be providing support to ensure that the maximum number of people can receive the best possible medical care.”

Related Links:
ETH Zurich

Diagnostic Ultrasound System
DC-80A
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Half Apron
Demi
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.